114 related articles for article (PubMed ID: 9933105)
21. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells.
Probst P; Skeiky YA; Steeves M; Gervassi A; Grabstein KH; Reed SG
Eur J Immunol; 1997 Oct; 27(10):2634-42. PubMed ID: 9368620
[TBL] [Abstract][Full Text] [Related]
22. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
Paul J; Karmakar S; De T
Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
[TBL] [Abstract][Full Text] [Related]
23. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
[TBL] [Abstract][Full Text] [Related]
24. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporin A-mediated killing of Leishmania major by macrophages is independent of reactive nitrogen and endogenous TNF-alpha and is not inhibited by IL-10 and 13.
Meissner U; Jüttner S; Röllinghoff M; Gessner A
Parasitol Res; 2003 Feb; 89(3):221-7. PubMed ID: 12541065
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptor 4 promotes control of Leishmania infantum infection through inducement of leishmanicidal activity in host macrophages: role of mitogen activated kinases.
Agallou M; Dotsika E; Frydas S; Karagouni E
J Biol Regul Homeost Agents; 2014; 28(1):41-52. PubMed ID: 24750790
[TBL] [Abstract][Full Text] [Related]
27. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling.
de Veer MJ; Curtis JM; Baldwin TM; DiDonato JA; Sexton A; McConville MJ; Handman E; Schofield L
Eur J Immunol; 2003 Oct; 33(10):2822-31. PubMed ID: 14515266
[TBL] [Abstract][Full Text] [Related]
28. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
29. Leishmania major parasites induced macrophage tolerance: implication of MAPK and NF-kappaB pathways.
Ben-Othman R; Dellagi K; Guizani-Tabbane L
Mol Immunol; 2009 Oct; 46(16):3438-44. PubMed ID: 19682748
[TBL] [Abstract][Full Text] [Related]
30. Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells.
Sartori A; Oliveira MA; Scott P; Trinchieri G
J Immunol; 1997 Sep; 159(6):2849-57. PubMed ID: 9300708
[TBL] [Abstract][Full Text] [Related]
31. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
32. Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A.1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase.
Balaraman S; Singh VK; Tewary P; Madhubala R
Mol Biochem Parasitol; 2005 Jan; 139(1):117-27. PubMed ID: 15610826
[TBL] [Abstract][Full Text] [Related]
33. In experimental leishmaniasis deficiency of CD18 results in parasite dissemination associated with altered macrophage functions and incomplete Th1 cell response.
Schönlau F; Scharffetter-Kochanek K; Grabbe S; Pietz B; Sorg C; Sunderkötter C
Eur J Immunol; 2000 Sep; 30(9):2729-40. PubMed ID: 11009109
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation.
Wang S; Chen Z; Hu C; Qian F; Cheng Y; Wu M; Shi B; Chen J; Hu Y; Yuan Z
J Immunol; 2013 May; 190(10):5142-51. PubMed ID: 23585678
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
[TBL] [Abstract][Full Text] [Related]
36. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
Wakil AE; Wang ZE; Locksley RM
Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
[TBL] [Abstract][Full Text] [Related]
37. Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice.
Dumas C; Muyombwe A; Roy G; Matte C; Ouellette M; Olivier M; Papadopoulou B
Infect Immun; 2003 Nov; 71(11):6499-509. PubMed ID: 14573672
[TBL] [Abstract][Full Text] [Related]
38. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major.
Louzir H; Melby PC; Ben Salah A; Marrakchi H; Aoun K; Ben Ismail R; Dellagi K
J Infect Dis; 1998 Jun; 177(6):1687-95. PubMed ID: 9607850
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
[TBL] [Abstract][Full Text] [Related]
40. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
Scharton-Kersten T; Afonso LC; Wysocka M; Trinchieri G; Scott P
J Immunol; 1995 May; 154(10):5320-30. PubMed ID: 7730635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
